INFINITAS CAPITAL GROUP
Single family office of Peter and Robin Lauber investing in residential Real Estate and Venture Capital opportunities
INFINITAS CAPITAL GROUP
Industry:
Real Estate Venture Capital
Founded:
2015-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Cloudflare Hosting Cloudflare DNS
Similar Organizations
Financiere Saint James
Financiere Saint James invests in venture capital (seed to late stage)
K5 Family Office
K5 is a single-family office predominantly investing in real estate and alternative asset classes.
Lymbersky Capital & Asset Management
Lymbersky Capital & Asset Management is a family office investing private wealth in real estate projects and selected venture capital deals.
Studer Family Office
Studer family office is manages and invests the assets of the Studer family and dear friends.
Current Advisors List
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-13 | Exporo | infinitas capital group investment in Venture Round - Exporo | N/A |
| 2022-05-30 | einwert | infinitas capital group investment in Pre Seed Round - einwert | 2 M EUR |
| 2022-01-26 | Storypod | infinitas capital group investment in Seed Round - Storypod | 4 M USD |
| 2021-10-26 | Cambrian Biopharma | infinitas capital group investment in Series C - Cambrian Biopharma | 100 M USD |
| 2021-10-05 | Customuse | infinitas capital group investment in Angel Round - Customuse | 1.5 M USD |
| 2021-09-01 | Olsam Group | infinitas capital group investment in Series A - Olsam Group | 120 M GBP |
| 2021-05-11 | Bullish Global | infinitas capital group investment in Venture Round - Bullish Global | 300 M USD |
| 2021-03-03 | ATAI Life Sciences | infinitas capital group investment in Series D - ATAI Life Sciences | 157 M USD |
| 2021-02-09 | Cambrian Biopharma | infinitas capital group investment in Series B - Cambrian Biopharma | 60 M USD |
| 2021-01-11 | Sensei Biotherapeutics | infinitas capital group investment in Series B - Sensei Biotherapeutics | 30 M USD |